Sung Yun Pai

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi Allogeneic transplantation successfully corrects immune defects, but not susceptibility to colitis, in a patient with nuclear factor-kappaB essential modulator deficiency
    Sung Yun Pai
    Division of Hematology Oncology, Children s Hospital Boston, Boston, MA 02115, USA
    J Allergy Clin Immunol 122:1113-1118.e1. 2008
  2. ncbi Allogeneic hematopoietic stem cell transplantation for X-linked ectodermal dysplasia and immunodeficiency: case report and review of outcomes
    Perdita Permaul
    Division of Immunology, Children s Hospital Boston, Boston, MA, USA
    Immunol Res 44:89-98. 2009
  3. ncbi IL-21 is the primary common ? chain-binding cytokine required for human B-cell differentiation in vivo
    Mike Recher
    Division of Immunology, Children s Hospital, Harvard Medical School, Boston, MA, USA
    Blood 118:6824-35. 2011
  4. ncbi p53+/mdm2- atypical lipomatous tumor/well-differentiated liposarcoma in young children: an early expression of Li-Fraumeni syndrome
    Larisa V Debelenko
    Department of Pathology, Children s Hospital Boston, 300 Longwood Avenue, Boston, MA 02115, USA
    Pediatr Dev Pathol 13:218-24. 2010
  5. ncbi Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: advances in biology and future directions for treatment
    Sung Yun Pai
    Division of Hematology Oncology, Children s Hospital Boston, Karp Family Research Laboratories, 8th Floor, Room 8214, 1 Blackfan Circle, Boston, MA 02115, USA
    Immunol Allergy Clin North Am 30:179-94. 2010

Detail Information

Publications5

  1. ncbi Allogeneic transplantation successfully corrects immune defects, but not susceptibility to colitis, in a patient with nuclear factor-kappaB essential modulator deficiency
    Sung Yun Pai
    Division of Hematology Oncology, Children s Hospital Boston, Boston, MA 02115, USA
    J Allergy Clin Immunol 122:1113-1118.e1. 2008
    ..Boys with X-linked ectodermal dysplasia and immunodeficiency caused by mutations of nuclear factor-kappaB essential modulator have defects in innate and adaptive immunity, and some have colitis...
  2. ncbi Allogeneic hematopoietic stem cell transplantation for X-linked ectodermal dysplasia and immunodeficiency: case report and review of outcomes
    Perdita Permaul
    Division of Immunology, Children s Hospital Boston, Boston, MA, USA
    Immunol Res 44:89-98. 2009
    ..We describe his treatment course as well as reconstitution of immune function and correction of osteopetrosis post-HSCT, and review the cases of allogeneic HSCT reported to date in the literature...
  3. ncbi IL-21 is the primary common ? chain-binding cytokine required for human B-cell differentiation in vivo
    Mike Recher
    Division of Immunology, Children s Hospital, Harvard Medical School, Boston, MA, USA
    Blood 118:6824-35. 2011
    ..Furthermore, in vitro stimulation with CD40L/IL-21 can predict in vivo B-cell immunity in IL2RG/JAK3 SCID after transplantation...
  4. ncbi p53+/mdm2- atypical lipomatous tumor/well-differentiated liposarcoma in young children: an early expression of Li-Fraumeni syndrome
    Larisa V Debelenko
    Department of Pathology, Children s Hospital Boston, 300 Longwood Avenue, Boston, MA 02115, USA
    Pediatr Dev Pathol 13:218-24. 2010
    ..Recognition of this lesion and its association is important for early diagnosis and subsequent tumor surveillance in the proband and affected family members...
  5. ncbi Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: advances in biology and future directions for treatment
    Sung Yun Pai
    Division of Hematology Oncology, Children s Hospital Boston, Karp Family Research Laboratories, 8th Floor, Room 8214, 1 Blackfan Circle, Boston, MA 02115, USA
    Immunol Allergy Clin North Am 30:179-94. 2010
    ..The current short- and long-term toxicities of HCT are the main stumbling block for the ability to cure every patient with WAS and X-linked thrombocytopenia, and much remains to be done...